ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1

CUSIP: 00484MAA4

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Debt / NOTE 1.750% 6/1
Market price (% of par)
85.02%
Total 13F principal
$324,511,750
Principal change
-$4,745,250
Total reported market value
$277,633,000
Number of holders
39
Value change
+$150,053
Number of buys
19
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 00484MAA4?
CUSIP 00484MAA4 identifies 00484MAA4 - ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q1 2017

As of 31 Mar 2017, ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by 39 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $324,511,750 in principal (par value) of the bond. The largest 10 bondholders included OAKTREE CAPITAL MANAGEMENT LP, BAKER BROS. ADVISORS LP, WOLVERINE ASSET MANAGEMENT LLC, CNH PARTNERS LLC, ANGELO GORDON & CO., L.P., CANYON CAPITAL ADVISORS LLC, Davidson Kempner Capital Management LP, D. E. Shaw & Co., Inc., CAMDEN ASSET MANAGEMENT L P /CA, and AMERIPRISE FINANCIAL INC. This page lists 39 institutional bondholders reporting positions for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.